Advanced Development of Antibacterial Countermeasures
Advanced Development of Antibacterial Countermeasures
抗菌对策的先进发展
批准号：
10410065
负责人：
TROY LISTER
金额：
$208.98万
依托单位：
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
项目状态：
已结题
起止时间：
2021-05-17 至 2023-01-16
关键词：
AddressAdvanced DevelopmentAnti-Bacterial AgentsAntibiotic ResistanceChemistryClinicalDevelopmentGram-Negative BacteriaPathway interactionsbacterial resistanceefficacy evaluationnovel therapeuticsphase I trialpre-clinicalproduct developmentresearch and developmentresearch clinical testingsafety assessmenttherapeutic candidate
中文摘要
翻译
支持一种有前景的耐药菌候选治疗药物的先进开发。支持的研发活动将使候选治疗产品通过产品开发途径取得进展，包括临床前和IND使能开发活动、化学优化/开发、GMP生产以及临床安全性和有效性评估。
英文摘要
To support the advanced development of a promising candidate therapeutic for resistant bacteria. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advanced Development of Antibacterial Countermeasures
-
批准号：10787969
-
项目类别：
-
资助金额：$149.46万
-
财政年份：2021
-
负责人：TROY LISTER
-
依托单位：
海外基金
